Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 211-220 of 411 for multiple

Edit search filters
  1. A Phase 1/2 Study Of CYT-0851 In B-Cell Malignancies And Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study To Evaluate Single Vs. Multiple Dose Regimens Of Privigen In Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

    Rochester, MN

  3. A Study Of JNJ‐68284528 Out‐of‐Specification (OOS) For Commercial Release In Patients With Multiple Myeloma

    Rochester, MN

  4. Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

    Jacksonville, FL

  5. A Study Evaluating The Safety And Effectiveness Of UCART Targeting CS1 In Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)

    Rochester, MN

  6. IXAZOMIB Plus Lenalidomide And Dexamethasone Versus Placebo Plus Lenalidomide And Dexamethasone In Adult Patients With Newly Diagnosed Multiple Myeloma

    Rochester, MN

  7. Study Of Single Agent CJM112, And PDR001 In Combination With LCL161 Or CJM112 In Patients With Multiple Myeloma

    Scottsdale/Phoenix, AZ

  8. Study Of Bromodomain And Extra-Terminal Protein (BET) Inhibitor RO6870810 As Mono- And Combination Therapy In Advanced Multiple Myeloma

    Jacksonville, FL

  9. Study Of Pomalidomide And Low Dose Dexamethasone With Or Without Pembrolizumab (MK-3475) In Refractory Or Relapsed And Refractory Multiple Myeloma (RrMM) (MK-3475-183/KEYNOTE-183)

    Jacksonville, FL

  10. A Study Evaluating The Addition Of Venetoclax (ABT-199) To Patients With Multiple Myeloma Who Are Receiving Bortezomib And Dexamethasone As Standard Therapy

    Rochester, MN

.

Mayo Clinic Footer